Top PBM to put Humira biosimilars on level playing field with AbbVie blockbuster

Humira is the best selling drug of all time. And as biosimilars for the drug venture onto the open market in Jan. 2023, one of the big three PBMs is making room for the biosimilars to compete on equal footing with the brand-name version.

UnitedHealth Group’s PBM OptumRx — one...

Click to view original post